Recent news on Moexipril

Teva Introduces Moexipril Hydrochloride and Hydrochlorothiazide ...  -  Mar 8, 2007
PharmaLive.com (press release),NORTH WALES, Pennsylvania, March 7, 2007 – Teva Pharmaceuticals is pleased to announce the introduction and availability of Moexipril Hydrochloride and

First-Time Generic Approvals: Aciphex, Zantac Syrup, Uniretic  -  Mar 13, 2007
Medscape (subscription)The FDA also approved moexipril HCl plus hydrochlorothiazide 12.5-mg/7.5-mg, 25-mg/15-mg, and 12.5-mg/15-mg tablets for the treatment of hypertension.

Teva Receives First US Approval For Generic UNIRETIC(R) Tablets  -  Mar 12, 2007
PipelineReview.com (press release),Announced today that the US Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application (ANDAfor Moexipril HCland

Market Report -- In Play (TEVA)  -  Mar 9, 2007
MSN MoneyTeva's Moexipril HCl and Hydrochlorothiazide Tablets are the first AB-rated generic equivalent of Schwarz Pharma's Uniretic Tablets, a product indicated for

Teva obtains 2 FDA approvals  -  Mar 11, 2007
Globes,The second approval is for Moexipril HCl and Hydrochlorothiazide Tablets, 7.5 mg/12.5 mg, 15 mg/12.5 mg and 15 mg/25 mg, AB-rated generic equivalent of

Teva Gets FDA OK for Uniretic Generic  -  Mar 9, 2007
Houston Chronicle,The company received approval to sell three different doses combining moexipril hydrochloride and hydrochlorothiazide, the active ingredients in Schwarz

Israel's Teva gets FDA nod for generic version of Uniretic  -  Mar 9, 2007
ReutersIn a news statement, Teva said shipment of the Moexipril HCl and Hydrochlorothiazide tablets will begin immediately. (Reporting by Sweta Singh in Bangalore)



First Quarter Report 2006: Schwarz Pharma with a Good Start  Apr 25, 2006
This is primarily attributable to the cardiovascular drugs Verelan® PM (verapamil HCI) and Uniretic® (moexipril), which achieved respective growth rates of ... - PharmaLive.com





SCHWARZ PHARMA /Full Year Report 2005  Feb 17, 2006
This increase is particularly due to the continuing sales recovery of the cardiovascular drug Univasc® (moexipril) in fiscal year 2005, after Teva ... - PharmaLive.com,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional